{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:48:06Z","timestamp":1791460086948,"version":"4.3.4"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,5,25]],"date-time":"2016-05-25T00:00:00Z","timestamp":1464134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,5,25]],"date-time":"2016-05-25T00:00:00Z","timestamp":1464134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s11154-016-9361-4","type":"journal-article","created":{"date-parts":[[2016,5,25]],"date-time":"2016-05-25T05:04:27Z","timestamp":1464152667000},"page":"529-535","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["The role of human parvovirus B19 and hepatitis C virus in the development of thyroid disorders"],"prefix":"10.1007","volume":"17","author":[{"given":"Poupak","family":"Fallahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Martina","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Vita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Benvenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,25]]},"reference":[{"key":"9361_CR1","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.autrev.2014.10.016","volume":"14","author":"A Antonelli","year":"2015","unstructured":"Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P. Autoimmune thyroid disorders. Autoimmun Rev. 2015;14:174\u201380.","journal-title":"Autoimmun Rev"},{"key":"9361_CR2","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s11154-016-9327-6","volume":"16","author":"S Benvenga","year":"2015","unstructured":"Benvenga S, Antonelli A, Vita R. Thyroid nodules and thyroid autoimmunity in the context of environmental pollution. Rev Endocr Metab Disord. 2015;16:319\u201340.","journal-title":"Rev Endocr Metab Disord"},{"key":"9361_CR3","first-page":"505","volume":"12","author":"K Morohoshi","year":"2011","unstructured":"Morohoshi K, Takahashi Y, Mori K. Viral infection and innate pattern recognition receptors in induction of Hashimoto\u2019s thyroiditis. Discov Med. 2011;12:505\u201311.","journal-title":"Discov Med"},{"key":"9361_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1743-422X-6-5","volume":"6","author":"R Desailloud","year":"2009","unstructured":"Desailloud R, Hober D. Viruses and thyroiditis: an update. Virol J. 2009;6:5.","journal-title":"Virol J"},{"key":"9361_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11154-013-9248-6","volume":"14","author":"AA Parsa","year":"2013","unstructured":"Parsa AA, Bhangoo A. HIV and thyroid dysfunction. Rev Endocr Metab Disord. 2013;14:127\u201331.","journal-title":"Rev Endocr Metab Disord"},{"key":"9361_CR6","first-page":"347","volume":"53","author":"N Ungnapatanin","year":"2012","unstructured":"Ungnapatanin N, Subauste JS, Henderson HM, Koch CA. Endocrine aspects in patients infected with the human immunodeficiency virus. J Miss State Med Assoc. 2012;53:347\u20138.","journal-title":"J Miss State Med Assoc"},{"key":"9361_CR7","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.5301\/jbm.5000115","volume":"30","author":"D Stamatiou","year":"2015","unstructured":"Stamatiou D, Derdas SP, Symvoulakis EK, Sakorafas GH, Zoras O, Spandidos DA. Investigation of BK virus, Epstein-Barr virus and human papillomavirus sequences in postoperative thyroid gland specimens. Int J Biol Markers. 2015;30:e104\u201310.","journal-title":"Int J Biol Markers"},{"key":"9361_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.4149\/av_2014_03_199","volume":"58","author":"LD Rogo","year":"2014","unstructured":"Rogo LD, Mokhtari-Azad T, Kabir MH, Rezaei F. Human parvovirus B19: a review. Acta Virol. 2014;58:199\u2013213.","journal-title":"Acta Virol"},{"key":"9361_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.tracli.2015.11.006","volume":"23","author":"A Servant-Delmas","year":"2016","unstructured":"Servant-Delmas A, Morinet F. Update of the human parvovirus B19 biology. Transfus Clin Biol. 2016;23:5\u201312.","journal-title":"Transfus Clin Biol"},{"key":"9361_CR10","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1002\/jmv.23852","volume":"86","author":"LA Adamson","year":"2014","unstructured":"Adamson LA, Fowler LJ, Ewald AS, Clare-Salzler MJ, Hobbs JA. Infection and persistence of erythrovirus B19 in benign and cancerous thyroid tissues. J Med Virol. 2014;86:1614\u201320.","journal-title":"J Med Virol"},{"key":"9361_CR11","first-page":"6039","volume":"156","author":"TB Vejlgaard","year":"1994","unstructured":"Vejlgaard TB, Nielsen OB. Subacute thyroiditis in parvovirus B19 infection. Ugeskr Laeger. 1994;156:6039\u201340.","journal-title":"Ugeskr Laeger"},{"key":"9361_CR12","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/S0140-6736(05)67184-X","volume":"366","author":"Y Munakata","year":"2005","unstructured":"Munakata Y, Kodera T, Saito T, Sasaki T. Rheumatoid arthritis, type 1 diabetes, and graves\u2019 disease after acute parvovirus B19 infection. Lancet. 2005;366:780.","journal-title":"Lancet"},{"key":"9361_CR13","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1016\/j.jinf.2007.05.173","volume":"55","author":"K Mori","year":"2007","unstructured":"Mori K, Munakata Y, Saito T, Tani J, Nakagawa Y, Hoshikawa S, et al. Intrathyroidal persistence of human parvovirus B19 DNA in a patient with Hashimoto\u2019s thyroiditis. J Infect. 2007;55:e29\u201331.","journal-title":"J Infect"},{"key":"9361_CR14","doi-asserted-by":"publisher","first-page":"e439","DOI":"10.1111\/j.1365-2230.2009.03470.x","volume":"34","author":"M Seishima","year":"2009","unstructured":"Seishima M, Shibuya Y, Suzuki S. Hyperthyroidism associated with human parvovirus B19 infection. Clin Exp Dermatol. 2009;34:e439\u201340.","journal-title":"Clin Exp Dermatol"},{"key":"9361_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1089\/vim.2008.0001","volume":"21","author":"HW Lehmann","year":"2008","unstructured":"Lehmann HW, Lutterb\u00fcse N, Plentz A, Akkurt I, Albers N, Hauffa BP, et al. Association of parvovirus B19 infection and Hashimoto\u2019s thyroiditis in children. Viral Immunol. 2008;21:379\u201383.","journal-title":"Viral Immunol"},{"key":"9361_CR16","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/sj.bjc.6604196","volume":"98","author":"JH Wang","year":"2008","unstructured":"Wang JH, Zhang WP, Liu HX, Wang D, Li YF, Wang WQ, et al. Detection of human parvovirus B19 in papillary thyroid carcinoma. Br J Cancer. 2008;98:611\u20138.","journal-title":"Br J Cancer"},{"key":"9361_CR17","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1089\/thy.2010.0307","volume":"21","author":"LA Adamson","year":"2011","unstructured":"Adamson LA, Fowler LJ, Clare-Salzler MJ, Hobbs JA. Parvovirus B19 infection in Hashimoto\u2019s thyroiditis, papillary thyroid carcinoma, and anaplastic thyroid carcinoma. Thyroid. 2011;21:411\u20137.","journal-title":"Thyroid"},{"key":"9361_CR18","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1002\/jmv.23595","volume":"85","author":"C Page","year":"2013","unstructured":"Page C, Hoffmann TW, Benzerdjeb N, Duverlie G, Sevestre H, Desailloud R. Detection of erythrovirus B19 in thyroidectomy specimens from graves\u2019 disease patients: a case-control study. J Med Virol. 2013;85:1414\u20139.","journal-title":"J Med Virol"},{"key":"9361_CR19","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1002\/jmv.24147","volume":"87","author":"C Page","year":"2015","unstructured":"Page C, Hoffmann TW, Benzerdjeb N, Desailloud R, Sevestre H, Duverlie G. Immunohistochemical- and PCR-based assay for the reproducible, routine detection of erythrovirus B19 in thyroid tissues. J Med Virol. 2015;87:1054\u20139.","journal-title":"J Med Virol"},{"key":"9361_CR20","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.humpath.2015.08.009","volume":"46","author":"L Wang","year":"2015","unstructured":"Wang L, Zhang WP, Yao L, Zhang W, Zhu J, Zhang WC, et al. PRDM1 expression via human parvovirus B19 infection plays a role in the pathogenesis of Hashimoto thyroiditis. Hum Pathol. 2015;46:1913\u201321.","journal-title":"Hum Pathol"},{"key":"9361_CR21","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/jmv.23963","volume":"87","author":"C Page","year":"2015","unstructured":"Page C, Duverlie G, Sevestre H, Desailloud R. Erythrovirus B19 and autoimmune thyroid diseases. Review of the literature and pathophysiological hypotheses. J Med Virol. 2015;87:162\u20139.","journal-title":"J Med Virol"},{"key":"9361_CR22","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.3748\/wjg.v13.i17.2436","volume":"13","author":"MJ Alter","year":"2007","unstructured":"Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol. 2007;13:2436\u201341.","journal-title":"World J Gastroenterol"},{"key":"9361_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/hep.21283","volume":"44","author":"JT Blackard","year":"2006","unstructured":"Blackard JT, Kemmer N, Sherman KE. Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology. 2006;44:15\u201322.","journal-title":"Hepatology"},{"key":"9361_CR24","doi-asserted-by":"publisher","first-page":"6518","DOI":"10.3748\/wjg.13.6518","volume":"13","author":"DV Stefanova-Petrova","year":"2007","unstructured":"Stefanova-Petrova DV, Tzvetanska AH, Naumova EJ, Mihailova AP, Hadjiev EA, Dikova RP, et al. Chronic hepatitis C virus infection: prevalence of extrahepatic manifestations and association with cryoglobulinemia in Bulgarian patients. World J Gastroenterol. 2007;13:6518\u201328.","journal-title":"World J Gastroenterol"},{"key":"9361_CR25","first-page":"65","volume":"16","author":"A Galossi","year":"2007","unstructured":"Galossi A, Guarisco R, Bellis L, Puoti C. Extrahepatic manifestations of chronic HCV infection. J Gastrointestin Liver Dis. 2007;16:65\u201373.","journal-title":"J Gastrointestin Liver Dis"},{"key":"9361_CR26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.4254\/wjh.v8.i2.83","volume":"8","author":"F Pastore","year":"2016","unstructured":"Pastore F, Martocchia A, Stefanelli M, Prunas P, Giordano S, Toussan L, et al. Hepatitis C virus infection and thyroid autoimmune disorders: a model of interactions between the host and the environment. World J Hepatol. 2016;8:83\u201391.","journal-title":"World J Hepatol"},{"key":"9361_CR27","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1001\/archinte.158.13.1445","volume":"158","author":"L Fernandez-Soto","year":"1998","unstructured":"Fernandez-Soto L, Gonzalez A, Escobar-Jimenez F, Vazquez R, Ocete E, Olea N, et al. Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy. Arch Intern Med. 1998;158:1445\u20138.","journal-title":"Arch Intern Med"},{"key":"9361_CR28","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1530\/eje.0.1320587","volume":"132","author":"D Preziati","year":"1995","unstructured":"Preziati D, La Rosa L, Covini G, Marcelli R, Rescalli S, Persani L, et al. Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a. Eur J Endocrinol. 1995;132:587\u201393.","journal-title":"Eur J Endocrinol"},{"key":"9361_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.amjmed.2004.01.023","volume":"117","author":"A Antonelli","year":"2004","unstructured":"Antonelli A, Ferri C, Pampana A, Fallahi P, Nesti C, Pasquini M, et al. Thyroid disorders in chronic hepatitis C. Am J Med. 2004;117:10\u20133.","journal-title":"Am J Med"},{"key":"9361_CR30","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/hep.1840180205","volume":"18","author":"A Tran","year":"1993","unstructured":"Tran A, Quaranta JF, Benzaken S, Thiers V, Chau HT, Hastier P, et al. High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology. 1993;18:253\u20137.","journal-title":"Hepatology"},{"key":"9361_CR31","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1089\/thy.1997.7.421","volume":"7","author":"RA Metcalfe","year":"1997","unstructured":"Metcalfe RA, Ball G, Kudesia G, Weetman AP. Failure to find an association between hepatitis C virus and thyroid autoimmunity. Thyroid. 1997;7:421\u20134.","journal-title":"Thyroid"},{"key":"9361_CR32","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/0168-8278(95)80216-9","volume":"22","author":"J Boadas","year":"1995","unstructured":"Boadas J, Rodr\u00edguez-Espinosa J, Enr\u00edquez J, Miralles F, Mart\u00ednez-Cerezo FJ, Gonz\u00e1lez P, et al. Prevalence of thyroid autoantibodies is not increased in blood donors with hepatitis C virus infection. J Hepatol. 1995;22:611\u20135.","journal-title":"J Hepatol"},{"key":"9361_CR33","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/j.1365-2265.1986.tb01658.x","volume":"24","author":"E Martino","year":"1986","unstructured":"Martino E, Macchia E, Aghini-Lombardi F, Antonelli A, Lenziardi M, Concetti R, et al. Is humoral thyroid autoimmunity relevant in amiodarone iodine-induced thyrotoxicosis (AIIT)?. Clin Endocrinol. 1986;24:627\u201333.","journal-title":"Clin Endocrinol"},{"key":"9361_CR34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1365-2265.2007.03009.x","volume":"68","author":"G Indolfi","year":"2008","unstructured":"Indolfi G, Stagi S, Bartolini E, Salti R, de Martino M, Azzari C, et al. Thyroid function and anti-thyroid autoantibodies in untreated children with vertically acquired chronic hepatitis C virus infection. Clin Endocrinol. 2008;68:117\u201321.","journal-title":"Clin Endocrinol"},{"key":"9361_CR35","first-page":"399","volume":"89","author":"U Watanabe","year":"1994","unstructured":"Watanabe U, Hashimoto E, Hisamitsu T, Obata H, Hayashi N. The risk factor for development of thyroid disease during interferon-alpha therapy for chronic hepatitis C. Am J Gastroenterol. 1994;89:399\u2013403.","journal-title":"Am J Gastroenterol"},{"key":"9361_CR36","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1159\/000184606","volume":"44","author":"C Carella","year":"1995","unstructured":"Carella C, Amato G, Biondi B, Rotondi M, Morisco F, Tuccillo C, et al. Longitudinal study of antibodies against thyroid in patients undergoing interferon-alpha therapy for HCV chronic hepatitis. Horm Res. 1995;44:110\u20134.","journal-title":"Horm Res"},{"key":"9361_CR37","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/S0002-9343(96)00259-8","volume":"101","author":"E Roti","year":"1996","unstructured":"Roti E, Minelli R, Giuberti T, Marchelli S, Schianchi C, Gardini E, et al. Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha. Am J Med. 1996;101:482\u20137.","journal-title":"Am J Med"},{"key":"9361_CR38","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1046\/j.1365-2265.1996.751768.x","volume":"44","author":"M Marazuela","year":"1996","unstructured":"Marazuela M, Garc\u00eda-Buey L, Gonz\u00e1lez-Fern\u00e1ndez B, Garc\u00eda-Monz\u00f3n C, Arranz A, Borque MJ, et al. Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy. Clin Endocrinol. 1996;44:635\u201342.","journal-title":"Clin Endocrinol"},{"key":"9361_CR39","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1530\/eje.0.1460743","volume":"146","author":"C Carella","year":"2002","unstructured":"Carella C, Mazziotti G, Morisco F, Rotondi M, Cioffi M, Tuccillo C, et al. The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism. Eur J Endocrinol. 2002;146:743\u20139.","journal-title":"Eur J Endocrinol"},{"key":"9361_CR40","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1089\/thy.2006.16.563","volume":"16","author":"A Antonelli","year":"2006","unstructured":"Antonelli A, Ferri C, Fallahi P, Ferrari SM, Ghinoi A, Rotondi M, et al. Thyroid disorders in chronic hepatitis C virus infection. Thyroid. 2006;16:563\u201372.","journal-title":"Thyroid"},{"key":"9361_CR41","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1001\/jama.297.18.2010","volume":"297","author":"TP Giordano","year":"2007","unstructured":"Giordano TP, Henderson L, Landgren O, Chiao EY, Kramer JR, El-Serag H, et al. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. J Am Med Assoc. 2007;297:2010\u20137.","journal-title":"J Am Med Assoc"},{"issue":"1 Suppl 48","key":"9361_CR42","first-page":"S39","volume":"26","author":"A Antonelli","year":"2008","unstructured":"Antonelli A, Ferri C, Galeazzi M, Giannitti C, Manno D, Mieli-Vergani G, et al. HCV infection: pathogenesis, clinical manifestations and therapy. Clin Exp Rheumatol. 2008;26(1 Suppl 48):S39\u201347.","journal-title":"Clin Exp Rheumatol"},{"key":"9361_CR43","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1002\/art.1780301121","volume":"30","author":"M Goldman","year":"1987","unstructured":"Goldman M, Lambert P, Tasiaux N, Vereerstraeten P, Sabot JP, Thoua Y, et al. Thyroid-stimulating immunoglobulins in mixed (type II) cryoglobulinemia associated with thyrotoxicosis. Arthritis Rheum. 1987;30:1318\u20139.","journal-title":"Arthritis Rheum"},{"key":"9361_CR44","first-page":"391","volume":"20","author":"A Castellano Higuera","year":"2003","unstructured":"Castellano Higuera A, Gonz\u00e1les Reimers E, Alarc\u00f3 Hern\u00e1ndez B, Santolaria Fern\u00e1ndez F, Rodr\u00edguez GM. Hypothyroidism, hemolytic anemia and cryoglobulinemia in a patient with hepatitis C virus infection: efficacy of treatment with alpha-interferon. An Med Interna. 2003;20:391\u20132.","journal-title":"An Med Interna"},{"key":"9361_CR45","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/qjmed\/hch088","volume":"97","author":"A Antonelli","year":"2004","unstructured":"Antonelli A, Ferri C, Fallahi P, Giuggioli D, Nesti C, Longombardo G, et al. Thyroid involvement in patients with overt HCV-related mixed cryoglobulinaemia. QJM. 2004;97:499\u2013506.","journal-title":"QJM"},{"key":"9361_CR46","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1001\/jama.281.17.1588","volume":"281","author":"A Antonelli","year":"1999","unstructured":"Antonelli A, Ferri C, Fallahi P. Thyroid cancer in patients with hepatitis C infection. JAMA. 1999;281:1588.","journal-title":"JAMA"},{"key":"9361_CR47","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/1097-0215(20000815)87:4<611::AID-IJC24>3.0.CO;2-N","volume":"87","author":"M Montella","year":"2000","unstructured":"Montella M, Crispo A, Pezzullo L, Izzo F, Fabbrocini G, Ronga D, et al. Is hepatitis C virus infection associated with thyroid cancer? A case-control study. Int J Cancer. 2000;87:611\u20132.","journal-title":"Int J Cancer"},{"key":"9361_CR48","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1034\/j.1600-0676.2001.210506.x","volume":"21","author":"M Montella","year":"2001","unstructured":"Montella M, Crispo A, de Bellis G, Izzo F, Frigeri F, Ronga D, et al. HCV and cancer: a case-control study in a high-endemic area. Liver. 2001;21:335\u201341.","journal-title":"Liver"},{"key":"9361_CR49","first-page":"693","volume":"20","author":"A Antonelli","year":"2002","unstructured":"Antonelli A, Ferri C, Fallahi P, Nesti C, Zignego AL, Maccheroni M. Thyroid cancer in HCV-related mixed cryoglobulinemia patients. Clin Exp Rheumatol. 2002;20:693\u20136.","journal-title":"Clin Exp Rheumatol"},{"key":"9361_CR50","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1530\/ERC-11-0028","volume":"18","author":"E Fiore","year":"2011","unstructured":"Fiore E, Rago T, Latrofa F, Provenzale MA, Piaggi P, Delitala A, et al. Hashimoto\u2019s thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine. Endocr Relat Cancer. 2011;18:429\u201337.","journal-title":"Endocr Relat Cancer"},{"key":"9361_CR51","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1089\/thy.2006.0194","volume":"17","author":"A Antonelli","year":"2007","unstructured":"Antonelli A, Ferri C, Fallahi P, Pampana A, Ferrari SM, Barani L, et al. Thyroid cancer in HCV-related chronic hepatitis patients: a case-control study. Thyroid. 2007;17:447\u201351.","journal-title":"Thyroid"},{"key":"9361_CR52","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1016\/S1590-8658(07)80005-3","volume":"39","author":"C Ferri","year":"2007","unstructured":"Ferri C, Antonelli A, Mascia MT, Sebastiani M, Fallahi P, Ferrari D, et al. HCV-related autoimmune and neoplastic disorders: the HCV syndrome. Dig Liver Dis. 2007;39:S13\u201321.","journal-title":"Dig Liver Dis"},{"key":"9361_CR53","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/infdis\/jis385","volume":"206","author":"MH Lee","year":"2012","unstructured":"Lee MH, Yang HI, Lu SN, Jen CL, You SL, Wang LY, et al. Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study. J Infect Dis. 2012;206:469\u201377.","journal-title":"J Infect Dis"},{"key":"9361_CR54","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/jmv.10431","volume":"70","author":"S Mihm","year":"2003","unstructured":"Mihm S, Schweyer S, Ramadori G. Expression of the chemokine IP-10 correlates with the accumulation of hepatic IFN-gamma and IL-18 mRNA in chronic hepatitis C but not in hepatitis B. J Med Virol. 2003;70:562\u201370.","journal-title":"J Med Virol"},{"key":"9361_CR55","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.autrev.2008.07.017","volume":"8","author":"A Antonelli","year":"2008","unstructured":"Antonelli A, Ferri C, Ferrari SM, Colaci M, Fallahi P. Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia. Autoimmun Rev. 2008;8:8\u201323.","journal-title":"Autoimmun Rev"},{"key":"9361_CR56","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.autrev.2013.10.010","volume":"13","author":"A Antonelli","year":"2014","unstructured":"Antonelli A, Ferrari SM, Giuggioli D, Ferrannini E, Ferri C, Fallahi P. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. Autoimmun Rev. 2014;13:272\u201380.","journal-title":"Autoimmun Rev"},{"key":"9361_CR57","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1677\/ERC-08-0337","volume":"16","author":"A Antonelli","year":"2009","unstructured":"Antonelli A, Ferrari SM, Fallahi P, Frascerra S, Piaggi S, Gelmini S, et al. Dysregulation of secretion of CXC alpha-chemokine CXCL10 in papillary thyroid cancer: modulation by peroxisome proliferator-activated receptor-gamma agonists. Endocr Relat Cancer. 2009;16:1299\u2013311.","journal-title":"Endocr Relat Cancer"},{"key":"9361_CR58","doi-asserted-by":"publisher","first-page":"E413","DOI":"10.1210\/jc.2010-0923","volume":"95","author":"A Antonelli","year":"2010","unstructured":"Antonelli A, Ferrari SM, Frascerra S, Pupilli C, Mancusi C, Metelli MR, et al. CXCL9 and CXCL11 chemokines modulation by peroxisome proliferator-activated receptor-alpha agonists secretion in graves\u2019 and normal thyrocytes. J Clin Endocrinol Metab. 2010;95:E413\u201320.","journal-title":"J Clin Endocrinol Metab"},{"key":"9361_CR59","unstructured":"Antonelli A, Fallahi P, Delle Sedie A, Ferrari SM, Maccheroni M, Bombardieri S, et al. High values of Th1 (CXCL10) and Th2 (CCL2) chemokines in patients with psoriatic arthtritis. Clin Exp Rheumatol. 2009;27:22\u20137."},{"key":"9361_CR60","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1055\/s-2000-9503","volume":"20","author":"EJ Gowans","year":"2000","unstructured":"Gowans EJ. Distribution of markers of hepatitis C virus infection throughout the body. Semin Liver Dis. 2000;20:85\u2013102.","journal-title":"Semin Liver Dis"},{"key":"9361_CR61","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1002\/jmv.21269","volume":"80","author":"J Bartolom\u00e9","year":"2008","unstructured":"Bartolom\u00e9 J, Rodr\u00edguez-I\u00f1igo E, Quadros P, Vidal S, Pascual-Miguela\u00f1ez I, Rodr\u00edguez-Montes JA, et al. Detection of hepatitis C virus in thyroid tissue from patients with chronic HCV infection. J Med Virol. 2008;80:1588\u201394.","journal-title":"J Med Virol"},{"key":"9361_CR62","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1378\/chest.130.2.526","volume":"130","author":"A Antonelli","year":"2006","unstructured":"Antonelli A, Fazzi P, Fallahi P, Ferrari SM, Ferrannini E. Prevalence of hypothyroidism and graves disease in sarcoidosis. Chest. 2006;130:526\u201332.","journal-title":"Chest"},{"key":"9361_CR63","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.metabol.2009.10.010","volume":"59","author":"A Antonelli","year":"2010","unstructured":"Antonelli A, Fallahi P, Mosca M, Ferrari SM, Ruffilli I, Corti A, et al. Prevalence of thyroid dysfunctions in systemic lupus erythematosus. Metabolism. 2010;59:896\u2013900.","journal-title":"Metabolism"},{"key":"9361_CR64","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.metabol.2008.04.023","volume":"57","author":"A Antonelli","year":"2008","unstructured":"Antonelli A, Ferri C, Fallahi P, Ferrari SM, Frascerra S, Carpi A, et al. Alpha-chemokine CXCL10 and beta-chemokine CCL2 serum levels in patients with hepatitis C-associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis. Metabolism. 2008;57:1270\u20137.","journal-title":"Metabolism"},{"key":"9361_CR65","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.cyto.2008.01.002","volume":"42","author":"A Antonelli","year":"2008","unstructured":"Antonelli A, Ferri C, Fallahi P, Ferrari SM, Frascerra S, Sebastiani M, et al. High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis. Cytokine. 2008;42:137\u201343.","journal-title":"Cytokine"},{"key":"9361_CR66","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1089\/jir.2010.0024","volume":"30","author":"A Antonelli","year":"2010","unstructured":"Antonelli A, Ferri C, Ferrari SM, De Marco S, Di Domenicantonio A, Centanni M, et al. Interleukin-1\u03b2, C-x-C motif ligand 10, and interferon-gamma serum levels in mixed cryoglobulinemia with or without autoimmune thyroiditis. J Interf Cytokine Res. 2010;30:835\u201342.","journal-title":"J Interf Cytokine Res"},{"key":"9361_CR67","first-page":"S17","volume":"29","author":"A Antonelli","year":"2011","unstructured":"Antonelli A, Ferri C, Ferrari SM, Di Domenicantonio A, Ferrari P, Pupilli C, et al. The presence of autoimmune thyroiditis in mixed cryoglobulinemia patients is associated with high levels of circulating interleukin-6, but not of tumor necrosis factor-alpha. Clin Exp Rheumatol. 2011;29:S17\u201322.","journal-title":"Clin Exp Rheumatol"},{"key":"9361_CR68","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.autrev.2007.02.019","volume":"7","author":"C Ferri","year":"2007","unstructured":"Ferri C, Antonelli A, Mascia MT, Sebastiani M, Fallahi P, Ferrari D, et al. B-cells and mixed cryoglobulinemia. Autoimmun Rev. 2007;7:114\u201320.","journal-title":"Autoimmun Rev"},{"key":"9361_CR69","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1464-5491.2008.02577.x","volume":"25","author":"A Antonelli","year":"2008","unstructured":"Antonelli A, Fallahi P, Ferrari SM, Pupilli C, d\u2019Annunzio G, Lorini R, et al. Serum Th1 (CXCL10) and Th2 (CCL2) chemokine levels in children with newly diagnosed type 1 diabetes: a longitudinal study. Diabet Med. 2008;25:1349\u201353.","journal-title":"Diabet Med"},{"key":"9361_CR70","doi-asserted-by":"publisher","unstructured":"Fallahi P, Ferrari SM, Ruffilli I, Elia G, Giuggioli D, Colaci M, et al. Incidence of thyroid disorders in mixed cryoglobulinemia: results from a longitudinal follow-up. Autoimmun Rev 2016; doi: 10.1016\/j.autrev.2016.03.012. [Epub ahead of print]","DOI":"10.1016\/j.autrev.2016.03.012"},{"key":"9361_CR71","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1586\/1744666X.2015.997214","volume":"11","author":"AL Zignego","year":"2015","unstructured":"Zignego AL, Gragnani L, Piluso A, Sebastiani M, Giuggioli D, Fallahi P, et al. Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection. Expert Rev Clin Immunol. 2015;11:15\u201331.","journal-title":"Expert Rev Clin Immunol"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-016-9361-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-016-9361-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-016-9361-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-016-9361-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T03:24:10Z","timestamp":1718594650000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11154-016-9361-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,25]]},"references-count":71,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["9361"],"URL":"https:\/\/doi.org\/10.1007\/s11154-016-9361-4","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,25]]},"assertion":[{"value":"25 May 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have nothing to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}